| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2006-05-22 15:12:47 UTC |
|---|
| Updated at | 2021-08-19 23:57:59 UTC |
|---|
| NP-MRD ID | NP0000273 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | 1-Methylguanine |
|---|
| Description | 1-Methylguanine is a naturally occurring modified purine derived from tRNA, found in elevated levels in the serum and urine of cancer patients (PMID: 2413515 ). Increase of 1-methylguanine in the urine of colorectal tumor bearing patients, has been justified either by a more rapid turnover of nucleic acids in tumor tissue or by an increase in the extent of their methylation (PMID: 9069642 ). |
|---|
| Structure | InChI=1S/C6H7N5O/c1-11-5(12)3-4(9-2-8-3)10-6(11)7/h2H,1H3,(H2,7,10)(H,8,9) |
|---|
| Synonyms | | Value | Source |
|---|
| N1-Methylguanine | ChEBI | | 1-Methyl-(8ci)-guanine | HMDB | | 1-Methyl-guanine | HMDB | | RRNA containing N1-methylguanine | HMDB |
|
|---|
| Chemical Formula | C6H7N5O |
|---|
| Average Mass | 165.1527 Da |
|---|
| Monoisotopic Mass | 165.06506 Da |
|---|
| IUPAC Name | 2-amino-1-methyl-6,7-dihydro-1H-purin-6-one |
|---|
| Traditional Name | 2-amino-1-methyl-7H-purin-6-one |
|---|
| CAS Registry Number | 938-85-2 |
|---|
| SMILES | CN1C(N)=NC2=C(NC=N2)C1=O |
|---|
| InChI Identifier | InChI=1S/C6H7N5O/c1-11-5(12)3-4(9-2-8-3)10-6(11)7/h2H,1H3,(H2,7,10)(H,8,9) |
|---|
| InChI Key | RFLVMTUMFYRZCB-UHFFFAOYSA-N |
|---|
| Experimental Spectra |
|---|
|
| | Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Predicted Spectra |
|---|
|
| Not Available | | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as 6-oxopurines. These are purines that carry a C=O group at position 6. Purine is a bicyclic aromatic compound made up of a pyrimidine ring fused to an imidazole ring. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Imidazopyrimidines |
|---|
| Sub Class | Purines and purine derivatives |
|---|
| Direct Parent | 6-oxopurines |
|---|
| Alternative Parents | |
|---|
| Substituents | - 6-oxopurine
- Pyrimidone
- Pyrimidine
- Azole
- Imidazole
- Heteroaromatic compound
- Vinylogous amide
- Lactam
- Azacycle
- Hydrocarbon derivative
- Organic oxide
- Organooxygen compound
- Organonitrogen compound
- Organic nitrogen compound
- Organopnictogen compound
- Organic oxygen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 64310 mg/L @ 25 °C (est) | The Good Scents Company Information System | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Mills GC, Schmalstieg FC, Goldblum RM: Urinary excretion of modified purines and nucleosides in immunodeficient children. Biochem Med. 1985 Aug;34(1):37-51. [PubMed:4052062 ]
- Porcelli B, Muraca LF, Frosi B, Marinello E, Vernillo R, De Martino A, Catinella S, Traldi P: Fast-atom bombardment mass spectrometry for mapping of endogenous methylated purine bases in urine extracts. Rapid Commun Mass Spectrom. 1997;11(4):398-404. [PubMed:9069642 ]
- Kerr SJ: Induction of adipocyte formation in 10T1/2 cells by 1-methylguanine and 7-methylguanine. Tumour Biol. 1985;6(2):115-21. [PubMed:2413515 ]
- Banys K, Giebultowicz J, Sobczak M, Wyrebiak R, Bielecki W, Wrzesien R, Bobrowska-Korczak B: Effect of Genistein Supplementation on the Progression of Neoplasms and the Level of the Modified Nucleosides in Rats With Mammary Cancer. In Vivo. 2021 Jul-Aug;35(4):2059-2072. doi: 10.21873/invivo.12475. [PubMed:34182481 ]
- Gatarek P, Kaluzna-Czaplinska J, Pawelczyk M, Jastrzebski K, Giebultowicz J, Glabinski A, Bobrowska-Korczak B: LC-MS/MS Determination of Modified Nucleosides in The Urine of Parkinson's Disease and Parkinsonian Syndromes Patients. Molecules. 2020 Oct 27;25(21). pii: molecules25214959. doi: 10.3390/molecules25214959. [PubMed:33120888 ]
- Parsons CL, Argade S, Evans RJ, Proctor J, Nickel JC, Rosenberg MT, Bosch PC: Role of urinary cations in the etiology of interstitial cystitis: A multisite study. Int J Urol. 2020 Sep;27(9):731-735. doi: 10.1111/iju.14293. Epub 2020 Jul 17. [PubMed:32677166 ]
|
|---|